Ticker Scorecard - ATHA Basics Company: Athira Pharma, Inc. IPO Date: September 18, 2020 Sector: Healthcare Industry: Biotech Market Cap: $19.33M Activated in VL: True Average Daily Range Avg Daily Range: $0.26 | 3.29% Avg Daily Range (30 D): $0.02 | 3.23% Avg Daily Range (90 D): $0.02 | 3.89% Institutional Daily Volume Avg Daily Volume: .57M Avg Daily Volume (30 D): .2M Avg Daily Volume (90 D): 2.58M Trade Size Avg Trade Size (Sh.): 195 Avg Trade Size (Sh.) (30 D): 581 Avg Trade Size (Sh.) (90 D): 815 Institutional Trades Total Inst.Trades: 147 Avg Inst. Trade: $1.77M Avg Inst. Trade (30 D): $.75M Avg Inst. Trade (90 D): $.75M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.81M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 222.62K     News Jul 10, 2024 @ 1:01 PM Athira (ATHA) Completes Dosing in Alzheimer's Stud... Source: N/A Jun 12, 2024 @ 11:00 AM Athira to Host Webinar Highlighting Potential for ... Source: Athira Pharma, Inc. May 29, 2024 @ 11:00 AM Athira Pharma to Participate in Upcoming June Conf... Source: Athira Pharma, Inc. May 17, 2024 @ 9:00 PM Athira Pharma Announces Proposed Settlement of Sto... Source: Athira Pharma, Inc. May 15, 2024 @ 8:05 PM Athira Pharma Reports First Quarter 2024 Financial... Source: Athira Pharma, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.84 $-.75 $-.7 Diluted EPS $-2.84 $-.75 $-.7 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -109.22M $ -28.74M $ -26.86M Operating Income / Loss $ -114.35M $ -29.62M $ -28.03M Cost of Revenue $ $ $ Net Cash Flow $ -90.95M $ -23.1M $ -73.9M PE Ratio